The results of the differential expression analysis, based on a limited number of TNBC data, indicated that IL-3Rα was highly expressed in TNBCs compared with luminal breast cancers (p = 0.017, padj = 0.026, (Figure 8A). The gene discussed is IL3RA; the disease is breast carcinoma.